medical_xpress
@zpcbeqyqyryncom
Twice-yearly depemokimab significantly reduces #NasalPolyps and obstruction symptoms in #ChronicRhinosinusitis with polyps, offering a promising long-term treatment with a favorable safety profile. @TheLancet https://t.co/ll6X1AY0wa https://t.co/gD1A0HCD8c
0 reply
0 recast
0 reaction